Risk Factors of (131)I-Induced Salivary Gland Damage in Thyroid Cancer Patients

CONTEXT: Sialadenitis and xerostomia are major adverse effects of (131)I therapy in thyroid cancer patients. The risk factors for these adverse effects, other than administered activity of (131)I, have not been investigated. OBJECTIVE: The aim of this study is to identify risk factors for (131)I-ind...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Endocrinol Metab
Autori principali: Hollingsworth, Brynn, Senter, Leigha, Zhang, Xiaoli, Brock, Guy N., Jarjour, Wael, Nagy, Rebecca, Brock, Pamela, Coombes, Kevin R., Kloos, Richard T., Ringel, Matthew D., Sipos, Jennifer, Lattimer, Ilene, Carrau, Ricardo, Jhiang, Sissy M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Endocrine Society 2016
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5095242/
https://ncbi.nlm.nih.gov/pubmed/27533304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2016-1605
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi